XML 125 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financing Receivables (Details 2) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Major Markets
Dec. 31, 2012
Major Markets
Dec. 31, 2013
Growth Markets
Dec. 31, 2012
Growth Markets
Dec. 31, 2013
Lease receivables
Dec. 31, 2012
Lease receivables
Dec. 31, 2011
Lease receivables
Dec. 31, 2013
Lease receivables
Major Markets
Dec. 31, 2012
Lease receivables
Major Markets
Dec. 31, 2011
Lease receivables
Major Markets
Dec. 31, 2013
Lease receivables
Growth Markets
Dec. 31, 2012
Lease receivables
Growth Markets
Dec. 31, 2011
Lease receivables
Growth Markets
Dec. 31, 2013
Loan receivables
Dec. 31, 2012
Loan receivables
Dec. 31, 2011
Loan receivables
Dec. 31, 2013
Loan receivables
Major Markets
Dec. 31, 2012
Loan receivables
Major Markets
Dec. 31, 2011
Loan receivables
Major Markets
Dec. 31, 2013
Loan receivables
Growth Markets
Dec. 31, 2012
Loan receivables
Growth Markets
Dec. 31, 2011
Loan receivables
Growth Markets
Financing Receivables                                                
Ending Balance $ 23,537 $ 22,510 $ 17,325 $ 16,701 $ 6,212 $ 5,808 $ 8,996 $ 9,174   $ 6,796 $ 7,036   $ 2,200 $ 2,138   $ 14,542 $ 13,336   $ 10,529 $ 9,666   $ 4,012 $ 3,670  
Collectively evaluated for impairment 23,219 22,254 17,206 16,570 6,013 5,684                                    
Individually evaluated for impairment 318 256 119 131 199 125                                    
Allowance for Credit Losses                                                
Allowance for credit losses, beginning balance 318 307 180 203 138 104 123 114 118 42 59 79 80 55 40 242 204 189 95 121 125 147 84 64
Write-offs (33) (15) (23) (14) (10) (1)                                    
Provision 84 28 (21) (9) 105 38                                    
Other (5) (2) 1 0 (6) (2)                                    
Allowance for credit losses, ending balance 365 318 137 180 228 138 123 114 118 42 59 79 80 55 40 242 204 189 95 121 125 147 84 64
Collectively evaluated for impairment 93 98 45 69 48 29                                    
Individually evaluated for impairment $ 272 $ 220 $ 93 $ 111 $ 179 $ 109